| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Affordable Medicines | — | — | — | $242.63M | $252.65M | $280.46M | $285.86M | $232.44M |
| AvKARE | $144.79M | $131.23M | $146.91M | $143.81M | $129.81M | $156.27M | $168.04M | $126.94M |
| Specialty | $50.71M | $50.71M | $50.71M | $61.48M | $61.48M | $61.48M | $61.48M | — |
| Total | $451.83M | $432.91M | $467.65M | $439.53M | $438.26M | $510.54M | $517.13M | $402.41M |
Specialty is derived from annual filings.